SKI Market

Indian Indices

Nifty

24,585.05 221.75
(0.91%)

Sensex

80,235.59 -368.49
( -0.46%)

Bank Nifty

55,510.75 505.85
( 0.92%)

Nifty IT

34,544.65 146.15
( 0.42%)

Global Indices

Nasdaq

44,012.84 -183.78
(-0.42%)

Dow Jones

6,397.00 13.45
(-0.21%)

Hang Seng

42,778.56 958.08
(2.29%)

Nikkei 225

9,129.71 33.98
(0.37%)

Forex

USD-INR

87.65 0.09
(0.10%)

EUR-INR

102.02 -0.05
(-0.04%)

GBP-INR

117.85 0.54
(0.46%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

173.2573795

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

24.97

777.89

EPS(TTM)

Face Value()

Div & Yield %

17.82

Back

Valiant Laboratories reports consolidated net profit of Rs 1.82 crore in the June 2025 quarter

Aug 08,2025

Net profit of Valiant Laboratories reported to Rs 1.82 crore in the quarter ended June 2025 as against net loss of Rs 0.51 crore during the previous quarter ended June 2024. Sales rose 147.99% to Rs 46.82 crore in the quarter ended June 2025 as against Rs 18.88 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	46.82	18.88	148
OPM %	5.10	-12.61	-
PBDT	2.98	0.37	705
PBT	2.45	-0.16	LP
NP	1.82	-0.51	LP

24,585.05 221.75 (0.91%)

80,235.59 -368.49 ( -0.46%)

55,510.75 505.85 ( 0.92%)

34,544.65 146.15 ( 0.42%)

44,012.84 -183.78 (-0.42%)

6,397.00 13.45 (-0.21%)

42,778.56 958.08 (2.29%)

9,129.71 33.98 (0.37%)

87.65 0.09 (0.10%)

102.02 -0.05 (-0.04%)

117.85 0.54 (0.46%)

0.59 0.00 (-0.24%)